Fig. 2

1
Fig. 2 1 μM ZD (h) - 100 nM Das (h) - 1 - 24 1 24 - - pErk1 pErk2 i) Akt pAkt Colo-357 Panc-1 - - - 1 - 24 1 24 - - 1 2 3 4 5 6 7 8 9 10 Lane ii) Erk1 Erk2 Panc-1 Colo357 HPDEC - - - - - - - 11 12 13 J. Pharmacology and Experimental Therapeutics Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src Soumya Jaganathan, Peibin Yue, and James Turkson

description

Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src. Soumya Jaganathan, Peibin Yue, and James Turkson. J. Pharmacology and Experimental Therapeutics. Fig. 2. Colo357. HPDEC. Panc-1. Panc-1. Colo-357. i). pErk1. pErk2. Erk1. Erk2. - PowerPoint PPT Presentation

Transcript of Fig. 2

Page 1: Fig. 2

Fig. 2

1 μM ZD (h) -100 nM Das (h) -

1-

241 24

--

pErk1pErk2

i)

Akt

pAkt

Colo-357Panc-1

-- -

1-

241 24

--1 2 3 4 5 6 7 8 9 10Lane

ii)

Erk1Erk2

Pan

c-1

Col

o3

57

HP

DE

C

--

--

-- -

11 12 13

J. Pharmacology and Experimental Therapeutics

Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src

Soumya Jaganathan, Peibin Yue, and James Turkson